A case of natalizumab‐associated progressive multifocal leukoencephalopathy followed by immune reconstitution inflammatory syndrome with difficulty in the timing of immunotherapy
Takamichi Sugimoto(Hiroshima University), Hirofumi Maruyama(Hiroshima University), Tomohisa Nezu(Hiroshima University), Kazuhide Ochi(Hiroshima University), Kazuo Nakamichi(National Institute of Infectious Diseases), Masahiro Nakamori(Hiroshima University), Yu Yamazaki(Hiroshima University), Shiro Aoki(Hiroshima University), Ruoyi Ishikawa(Hiroshima University), Megumi Nonaka(Hiroshima University), Shuichiro Neshige(Hiroshima University)
Cited by 2
Related Papers
Carotid Intima-Media Thickness for Atherosclerosis
|Journal of Atherosclerosis and Thrombosis|2015|311
The Japan Statin Treatment Against Recurrent Stroke (J-STARS): A Multicenter, Randomized, Open-label, Parallel-group Study
|EBioMedicine|2015|124
Pretreatment ASPECTS on DWI predicts 3-month outcome following rt-PA
|Neurology|2010|106